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relatively intact, and that only coupling 
between typical SMC bundles along the 
renal pelvis was aff ected. 
 Blockade of pacemaker activity as a 
result of lack of a PG drive and / or cell-to-
cell uncoupling can easily be tested by the 
application of excitatory PGs or upon 
electrical stimulation of small regions of 
the renal pelvis to see whether propagat-
ing contractions can be re-established. 
 Finally, the use of video imaging and a 
membrane potential – sensitive dye by 
Hurtado  et al. 8 provides a new, elegant 
means of directly correlating propagating 
contractions within the muscle wall of the 
upper urinary tract of the mouse with tis-
sue depolarization, which is far simpler 
than previous simultaneous recordings of 
muscle tension and action potential 
 discharge with either intracellular or 
extracellular membrane potential record-
ing techniques but is analogous to the 
recent imaging of contracting prepara-
tions with Ca 2  +   fl uorophores. 4 
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 Hospitalization for community-acquired 
pneumonia (CAP) is common in many 
economically developed countries. 1 – 3 
Surveillance data from several European 
countries and the United States indicate 
that the number of hospitalizations for 
CAP has increased over the past several 
decades. 1,2,4 Between 1998 and 2002, 5.8 % 
of hospitalizations for US Medicare reci-
pients (adults     65 years of age) had CAP 
listed as the primary discharge diagnosis, 
and CAP was listed as a contributing cause 
for 9.1 % of hospitalizations during this 
same time period. 5 
 Acute kidney injury (AKI) occurs in a 
substantial proportion of hospitalized 
patients 6,7 and is strongly associated with 
adverse outcomes. Sepsis and septic shock 
are important causes of AKI in critically 
ill patients. Some studies suggest that 
these factors contribute to more than 50 % 
of cases of AKI in the intensive care unit. 7 
AKI is associated with longer hospitaliza-
tions, need for transfer to an intensive care 
unit, and increased mortality. 6,8 Th e mor-
tality associated with AKI can be extraor-
dinarily high and extends beyond 
in-hospital mortality 6,7 to longer-term 
outcomes. 9,10 In a meta-analyis of pub-
lished studies, AKI was associated with a 
relative risk for mortality of 2.59 (95 % 
confi dence interval: 1.97 – 3.42). 8 
 Given its high prevalence and its asso-
ciation with adverse outcomes, the epide-
miology and pathogenesis of AKI is an 
area of active research interest. Many of the 
previous epidemiological studies of AKI have 
methodological limitations that may limit 
their utility. 11 Although prospective cohort 
studies provide, in general, the strongest 
evidence for an association between a risk 
factor and an outcome, such studies are 
not well suited for determining the 
 incidence of rare outcome events. Th is is 
a particular problem for studies investi-
gating the role of pre-hospitalization risk 
 factors for AKI. Very large populations are 
needed to generate reliable risk estimates. 
Therefore, most studies of AKI do not 
have reliable pre-hospitalization data 
available for analysis. Th e importance of 
preexisting chronic kidney disease as a 
risk factor for acquiring AKI, as well as a 
determinant of poor outcome, is not well 
established. 12 Amdur  et al. 13 reported that 
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 Acute kidney injury in sepsis: 
questions answered, 
but others remain 
 Paul  Muntner 1 , 2 and  David G.  Warnock 2 
 Acute kidney injury (AKI) is a serious complication of sepsis in the 
intensive care setting, with associated increases in the likelihood of 
death, prolonged hospital stay, and increased costs of care. Increased 
risk of developing AKI has now been recognized for patients admitted 
with sepsis and community-acquired pneumonia. Chronic kidney 
disease appears to increase the risk of developing AKI, while short- and 
long-term mortality risks were associated with the absolute increase in 
serum creatinine during hospitalization. 
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the 6-year risk of developing severe 
chronic kidney disease was less infl u-
enced by the premorbid level of kidney 
function than by whether the patient had 
had AKI as an inpatient. Both pre-admis-
sion chronic kidney disease and AKI as 
an inpatient were associated with all-
cause mortality during 75 months of 
follow-up aft er discharge. Chertow  et al. 6 
reached a similar conclusion about the 
risk of inpatient mortality; absolute as 
well as fractional changes in serum cre-
atinine were associated with increased 
inpatient mortality. Finally, there is 
clearly a competing risk between morta-
lity and progression of AKI to end-stage 
kidney disease requiring chronic dialy-
sis, 8,13,14 especially in elderly patients, as 
has also been described in patients with 
chronic kidney disease. 15 – 17 
 There is continuing interest in the 
appropriate definitions for diagnosis 
and outcomes of AKI. 18 Several defi ni-
tions for AKI have been proposed, using 
arbitrary cutoff points for changes in 
serum creatinine, 19 or more  ‘ physiologi-
cally ’ based approaches that include 
graded changes in kidney function, the 
severity of which predicts overall out-
come. 20,21 Recent studies have empha-
sized that even small increases in serum 
creatinine during hospitalization can 
be associated with adverse short- and 
long-term outcomes. 8,9 
 Murugan and colleagues (this issue) pro-
vide new data on sepsis-related AKI. 22 Th e 
analyses in this report were based on 
 hospitalized patients enrolled in the 
Genetic and Infl ammatory Markers of Sep-
sis (GenIMS) study. Th is study enrolled 
1836 patients with CAP presenting to the 
emergency departments of 28 hospitals in 
the United States. Th e authors addressed 
three important aims. First, they assessed 
risk factors for the development of AKI 
among patients hospitalized with CAP. 
Second, they determined mortality rates 
associated with the development of AKI 
over a 1-year follow-up period. Finally, they 
investigated immune, coagulation, and 
fi brinolysis pathways for developing sepsis. 
In this study, 34 % of patients admitted with 
CAP developed AKI, and those who devel-
oped AKI were older and more likely to be 
white and to have chronic kidney disease 
and diabetes. Patients admitted with CAP 
who presented with or developed AKI 
were more likely to require transfer to the 
intensive care unit and had longer hospital 
stays. AKI was associated with increased 
100-day mortality. Th e mortality rate of 
those with AKI returned to the level of 
those without AKI over several months 
but then increased over the next 3 years. 
 Th e work by Murugan and colleagues 22 
provides a substantial advance over prior 
studies by studying sepsis and AKI in CAP. 
Many studies have investigated sepsis and 
AKI in severely ill patients admitted to 
intensive care units. In this respect, the 
current study represents a major step for-
ward because the majority of the patients 
who developed AKI did not require trans-
fer to an intensive care unit. However, the 
results of the study by Murugan  et al. 22 
have to be considered in the context of 
several important caveats. First, although 
the authors used  ‘ premorbid ’ serum cre-
atinine values, these values appear to be 
imputed for 1745 patients (  >  90 % of the 
cohort). Th erefore, two-thirds of patients 
with AKI presented with decreased kidney 
function at the time of hospital admission. 
Few data from prior studies are available 
to assess the impact of  ‘ premorbid ’ renal 
function on the incidence of AKI. 
 Th e authors applied the RIFLE crite-
ria 20,23 to classify AKI, but it does not 
appear that the urine output criteria were 
used. Most of the patients were not in an 
intensive care unit; this makes it less likely 
that accurate urine output rates were avail-
able to help with the diagnosis of AKI. 24 
Th ere was a clear-cut risk of mortality that 
increased with the severity of AKI. Th e 
 ‘ Risk ’ criterion is less sensitive than the 
Acute Kidney Injury  Network criteria 21 for 
detecting AKI, so there is a possibility that 
milder cases of AKI were missed. In fur-
ther analyses, it was shown that the risk of 
mortality was associated with both abso-
lute and relative changes in kidney func-
tion when the investigators treated serum 
creatinine as a continuous variable rather 
than using the RIFLE criteria. Th e risks for 
adverse outcomes were the same when 
absolute changes in serum creatinine were 
compared with relative changes ( Figure 1 ); 
the increased risk for all-cause mortality 
associated with a rise in serum creatinine 
during the hospitalization appeared to be 
the same regardless of the base line serum 
creatinine level, confi rming the previous 
report of Chertow  et al. 6 Th is observation 
supports the thesis that absolute risk for 
poor outcomes is more strongly related to 
acute changes in kidney function than to 
baseline kidney function. Although 
patients with chronic kidney disease at 
baseline may carry a greater risk of deve-
loping AKI, the risk for  mortality appears 
to be more strongly associated with the 
absolute increase in serum creatinine. 
 Murugan and colleagues 22 should 
be commended for answering several 
important questions. Th e hazard ratio 
of all-cause mortality was not constant 
over time, so they explored alternatives 
to the usual proportional hazard models 
for survival analysis. Th e early risk of 
 Figure 1  |  Forest plot of adjusted hazard ratios ( ± 95 % confidence interval) for risk of all-cause 
mortality with acute kidney injury. Survival analysis for patients admitted with community-
acquired pneumonia:  ‘ absolute ’ refers to the increment in serum creatinine compared with 
admission level;  ‘ relative ’ refers to the change in serum creatinine relative to the admission value. 
(Data from ref.  22 .) 
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death associated with CAP and AKI was 
attenuated over the fi rst 3 months, a fi nd-
ing that brings to mind accele rated fail-
ure time models for survival analysis. 25 
 The findings of Murugan and col-
leagues 22 highlight the many unanswered 
questions surrounding AKI. Th ese range 
from pre-hospitalization risk factors to 
post-hospitalization risk for end-stage 
renal disease. Data from large-scale, rig-
orously designed, community-based epi-
demiological studies are clearly needed to 
identify the risk factors for AKI. Such 
data should provide key components for 
the development of algorithms for the 
early identifi cation of patients at high risk 
for AKI. Furthermore, well-designed 
studies are needed to assess the outcomes 
following hospitalization with AKI. In 
conclusion, we applaud Murugan and 
colleagues 22 for their study, which extends 
the range of interest in AKI outside of the 
intensive care unit, and we hope that it 
leads to additional studies that will 
uncover the causes and consequences of 
AKI and improve patient care. 
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 Glomerular filtration rate (GFR) is 
 generally accepted to refl ect the number 
of normally functioning glomeruli in the 
kidney. For this reason, GFR is an impor-
tant parameter used to assess renal 
 function in both clinical medicine and 
animal models of kidney disease. 1 Accu-
rate  measurement of GFR is critical for 
determining the severity of kidney injury, 
determining the effi  cacy of therapy aimed 
at slowing progressive renal disease, and 
making clinical decisions regarding 
patient care. Estimated GFR is commonly 
used to determine whether a patient can 
tolerate a drug or imaging contrast mate-
rial, and when a kidney disease patient 
 Better nephrology 
for mice — and man 
 Matthew D.  Breyer 1 and  Zhonghua  Qi 1   
 The use of creatinine to estimate glomerular filtration rate in patients is 
prone to well-described artifacts that impact its interpretation. Eisner 
 et al. now show that the impact of creatinine secretion on creatinine 
clearance is even larger in mice than in humans, raising questions 
regarding the utility of creatinine for measuring glomerular filtration 
rate in mice. 
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